Kazia Therapeutics Limited
Clinical trials sponsored by Kazia Therapeutics Limited, explained in plain language.
Kazia Therapeutics Limited
KZIA
NASDAQ
A biopharmaceutical company developing oncology therapies, particularly for brain cancer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.